臺灣結核病實作指引, published by 衛福部疾病管制署. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/omnifhir/tb/ and changes regularly. See the Directory of published versions
Profile: 分生二線藥物報告-Observation Moleculex
status: Final
category: Laboratory
code: 分生二線藥物報告
effective: 2026-02-18
performer: Unnamed Organization (Healthcare Provider) (Provider number: 0401180014 (use: official))
component
code: FLQ
value: 無法判定
component
code: KM
value: 無法判定
component
code: AMK
value: 無法判定
component
code: CM
value: 無法判定
component
code: ETH
value: 無法判定
component
code: PZA
value: 無法判定